Prevail Innovative Wealth Advisors LLC grew its position in abrdn Healthcare Investors (NYSE:HQH - Free Report) by 69.6% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 62,394 shares of the financial services provider's stock after purchasing an additional 25,607 shares during the quarter. Prevail Innovative Wealth Advisors LLC owned approximately 0.12% of abrdn Healthcare Investors worth $1,013,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of HQH. Cambridge Investment Research Advisors Inc. increased its position in abrdn Healthcare Investors by 18.6% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 83,775 shares of the financial services provider's stock worth $1,361,000 after acquiring an additional 13,147 shares during the period. Wealth Enhancement Advisory Services LLC bought a new position in abrdn Healthcare Investors during the first quarter worth $189,000. Baird Financial Group Inc. increased its position in abrdn Healthcare Investors by 45.2% during the fourth quarter. Baird Financial Group Inc. now owns 97,843 shares of the financial services provider's stock worth $1,570,000 after acquiring an additional 30,451 shares during the period. Ameriprise Financial Inc. increased its position in abrdn Healthcare Investors by 10.4% during the fourth quarter. Ameriprise Financial Inc. now owns 287,607 shares of the financial services provider's stock worth $4,616,000 after acquiring an additional 27,043 shares during the period. Finally, Raymond James Financial Inc. bought a new position in abrdn Healthcare Investors during the fourth quarter worth $15,049,000. Institutional investors own 32.60% of the company's stock.
abrdn Healthcare Investors Trading Down 0.5%
HQH stock traded down $0.08 on Friday, reaching $15.69. 296,670 shares of the company were exchanged, compared to its average volume of 199,912. abrdn Healthcare Investors has a 12 month low of $13.77 and a 12 month high of $19.79. The stock's fifty day moving average price is $15.58 and its 200 day moving average price is $16.24.
abrdn Healthcare Investors Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Thursday, May 22nd were paid a dividend of $0.54 per share. The ex-dividend date was Thursday, May 22nd. This represents a $2.16 dividend on an annualized basis and a yield of 13.77%. This is an increase from abrdn Healthcare Investors's previous quarterly dividend of $0.50.
About abrdn Healthcare Investors
(
Free Report)
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Further Reading
Before you consider abrdn Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and abrdn Healthcare Investors wasn't on the list.
While abrdn Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
